[1]广维,朱红,姚树兰,等.伊那西普治疗银屑病的十年回顾[J].中国皮肤性病学杂志,2012,(08):745-747.
 GUANG Wei,ZHU Hong,YAO Shu-lan,et al.A 10-year Review of Etanercept in the Treatment of Psoriasis[J].The Chinese Journal of Dermatovenereology,2012,(08):745-747.
点击复制

伊那西普治疗银屑病的十年回顾
分享到:

《中国皮肤性病学杂志》[ISSN:1001-7089/CN:61-1197/R]

卷:
期数:
2012年08期
页码:
745-747
栏目:
综述
出版日期:
2012-08-30

文章信息/Info

Title:
A 10-year Review of Etanercept in the Treatment of Psoriasis
作者:
广维;朱红;姚树兰;何春涤;
中国医科大学附属第一医院皮肤科;
Author(s):
GUANG WeiZHU HongYAO Shu-lanHE Chun-di
First Affiliated Hospital of China Medical University,Shenyang 110001,China
关键词:
伊那西普银屑病疗效不良反应
Keywords:
Etanercept Psoriasis Efficacy Adverseeffects
分类号:
R758.63
文献标志码:
A
摘要:
伊那西普是新一代的生物制剂,为近年来自身免疫性疾病领域的热门治疗药物。这些药物大多抑制在慢性炎症过程中起关键作用的肿瘤坏死因子。本文介绍了伊那西普治疗银屑病的临床疗效和作用机制,重点总结近十年来伊那西普的长期疗效和不良反应。
Abstract:
Etanercept is a member of a new generation of biological agents,which have caused great enthusiasm in the field of autoimmune disorders in recent years.Most of these agents are antagonists of tumor necrosis factor,which was one of the key cytokines in the chronic inflammatory process.This review provides an introduction to etanercept and describes its clinical efficacy in psoriasis.The mechanisms of action is also been discussed.Focus has been placed on the data of the past 10 years on long-term efficacy and adverse events.

相似文献/References:

[1]唐娟,张晓艳,宋佩华,等.寻常性银屑病患者皮损及外周血单一核细胞中IL-17A的表达[J].中国皮肤性病学杂志,2012,(08):689.
 TANG Juan,ZHANG Xiao-yan,SONG Pei-hua,et al.Expression of IL-17A in Involved Lesions and Blood Mononuclear Cells of Patients with Psoriaisis[J].The Chinese Journal of Dermatovenereology,2012,(08):689.
[2]戴莎,王秀丽,宋心葵,等.银屑病患者410例合并代谢综合征分析[J].中国皮肤性病学杂志,2012,(08):700.
 DAI Sha,WANG Xiu-li,SONG Xin-kui,et al.Analysis of 410 Cases of Psoriasis Patients with Metabolic Syndrome[J].The Chinese Journal of Dermatovenereology,2012,(08):700.
[3]谢韶琼,汪青良,宋勋,等.凉血润肤汤治疗寻常性银屑病42例疗效观察[J].中国皮肤性病学杂志,2012,(08):743.
 XIE Shao-qiong,WANG Qing-liang,SONG Xun,et al.Clinical Observation of Liangxierunfu Decoction on 42 Cases of Psoriasis Vulgaris[J].The Chinese Journal of Dermatovenereology,2012,(08):743.
[4]史航,刘晓明,林熙然,等.银屑病发病与创伤愈合机制的比较[J].中国皮肤性病学杂志,2012,(08):748.
 SHI Hang,LIU Xiao-ming,LIN Xi-ran.A Comparison on Pathogenesis of Psoriasis and Mechanism of Wound Healing[J].The Chinese Journal of Dermatovenereology,2012,(08):748.
[5]刘晓洁,张峻岭,刘雪,等.头皮银屑病和脂溢性皮炎的皮肤镜特征分析[J].中国皮肤性病学杂志,2015,(01):36.[doi:10.13735/j.cjdv.1001-7089.2015.0036]
 LIU Xiao jie,ZHANG Jun ling,LIU Xue,et al.Analysis of Dermoscopic Criteria for Scalp Psoriasis and Scalp Seborrheic Dermatitis[J].The Chinese Journal of Dermatovenereology,2015,(08):36.[doi:10.13735/j.cjdv.1001-7089.2015.0036]
[6]王彩梅,汤洁,向志,等.甲损害在泛发性脓疱型银屑病中的临床意义[J].中国皮肤性病学杂志,2015,(01):44.[doi:10.13735/j.cjdv.1001-7089.2015.0044]
 WANG Cai mei,TANG Jie,XIANG Zhi,et al.Clinical Significance of Nail Involvement in Generalized Pustular Psoriasis[J].The Chinese Journal of Dermatovenereology,2015,(08):44.[doi:10.13735/j.cjdv.1001-7089.2015.0044]
[7]李珺莹,李红.酪氨酸激酶及其抑制剂与免疫性皮肤病的研究进展[J].中国皮肤性病学杂志,2015,(01):93.[doi:10.13735/j.cjdv.1001-7089.2015.0093]
 LI Jun ying,LI Hong.Tyrosine Kinases and its Inhibitors in Immune Dermatologic Diseases[J].The Chinese Journal of Dermatovenereology,2015,(08):93.[doi:10.13735/j.cjdv.1001-7089.2015.0093]
[8]段茜,程燕,储蕾,等.银屑病与高血压病的相关性分析[J].中国皮肤性病学杂志,2015,(02):143.[doi:10.13735/j.cjdv.1001-7089.201404140]
 DUAN Xi,CHENG Yan,CHU Lei,et al.The Correlation between Psoriasis and Hypertension[J].The Chinese Journal of Dermatovenereology,2015,(08):143.[doi:10.13735/j.cjdv.1001-7089.201404140]
[9]杨颜龙,张禁,易松柏,等.阿维A胶囊联合复方甘草酸苷注射液治疗红皮病型银屑病30例临床观察[J].中国皮肤性病学杂志,2015,(02):217.[doi:10.13735/j.cjdv.1001-7089.201403167]
 YANG Yan long,ZHANG Jin,YI Song bai,et al.Clinical Observation of 30 Acitretin Capsules Combine with Compound Glycyrrhizin Injection in the Treatment of Patients with Erythrodermic Psoriasis[J].The Chinese Journal of Dermatovenereology,2015,(08):217.[doi:10.13735/j.cjdv.1001-7089.201403167]
[10]孙景英,普雄明,吴卫东.CXCL9和Smad3在新疆维吾尔族寻常性银屑病患者皮损中的表达[J].中国皮肤性病学杂志,2015,(03):242.[doi:10.13735/j.cjdv.1001-7089.201407083]
 SUN Jing ying,PU Xiong ming,WU Wei dong.The Expression of CXCL9 and Smad3 in Psoriasis Vulgaris of Xinjiang Uyghur Patients[J].The Chinese Journal of Dermatovenereology,2015,(08):242.[doi:10.13735/j.cjdv.1001-7089.201407083]

更新日期/Last Update: 2012-08-30